5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Concord Biotech Ltd.

•
concordbiotech.comBSE: 543960NSE: CONCORDBIO
Market Cap₹ 15,762 Cr.
Current Price
High / Low₹ 1,704 / 987
Stock P/E57.2
Book Value₹ 198
Price to Book5.27
Dividend Yield0.50 %
ROCE18.0 %
ROE13.5 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 25.6%
  • Company has consistently been profitable over the last 5 years
  • Latest quarter profit grew 31.0% YoY, showing strong momentum
  • Company has been maintaining a healthy dividend payout of 30.3%

CONS

  • Recent results are weak - TTM profit is down 26.0% versus prior year
  • Company has delivered a poor profit growth of 2.0% over past five years
  • Operating margins have contracted to 34.9% from 45.0%
  • Stock is trading at 5.3x its book value
  • Expensive relative to growth - PEG of 22.1
  • Inventory has been piling up - inventory days up from 68 to 98

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY TOTAL MKTNIFTY 500NIFTY SMLCAP 250
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.103620.702139.4220263.101191.0018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.CONCORDBIO1506.6557.2415762.000.5057.7030.96257.4926.2318.0432.49
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
195262241319216310244430204247278326257
123143135185135174146239143159179208193
Operating Profit72119106134811379819061889911964
OPM %37.03%45.43%43.99%42.10%37.66%44.06%40.11%44.30%30.10%35.82%35.63%36.35%24.95%
788111010159141371513
Interest1100000000000
Depreciation13131414131313151818192018
Profit before Tax65113100131781339918557838711478
Tax %25.44%25.35%25.51%25.74%25.50%25.95%25.40%23.32%25.63%27.13%25.92%22.42%26.35%
Net Profit00006096761404463648858
5.217.747.419.085.709.157.2613.424.216.036.088.465.52

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
5126177138531,0171,2001,0551,108
308289439505585693687738
Operating Profit205328274349432507368370
OPM %39.92%53.15%38.42%40.86%42.50%42.23%34.88%33.40%
3114233534444948
Interest116103110
Depreciation2128505454547475
Profit before Tax213313238322413495345363
Tax %20.86%24.89%26.35%25.44%25.32%24.85%24.78%25.19%
Net Profit169235175240308372259271
EPS177.8222.4516.7222.9529.4535.5224.94—
Dividend Payout %3.38%30.03%27.84%29.76%29.71%30.12%30.27%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
11%
3 Years:
7%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
2%
3 Years:
3%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
14%
1 Year:
-8%

RETURN ON EQUITY

10 Years:
—
5 Years:
19%
3 Years:
19%
Last Year:
14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jul 24

₹ 7.55

Rs.7.5500 per share(755%)Final Dividend

2025

Sep 3

₹ 10.70

Rs.10.7000 per share(1070%)Final Dividend

2024

Jun 21

₹ 8.75

Rs.8.7500 per share(875%)Dividend

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital10101010101010
Minority Interest000000-2
7619901,0941,2801,5161,8022,007
51886131211
Trade Payables7146839494113102
1561792559978107113
Total Liabilities1,0491,3131,5021,5141,7012,0342,232
240546573593575795789
Capital Work in Progress14118741732115078
19914174137246335491
111154195212208240326
0000350522460
Cash & Bank361894347114
355393497355649274
Total Assets1,0491,3131,5021,5141,7012,0342,232

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
204242268316265245267
Cash from Investing-113-195-112-158-155-160-143
Cash from Financing-4331-100-85-99-99-113
-13-4312-1411

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
44.0844.0844.0844.0844.0844.0844.0844.0844.08
7.118.108.339.359.108.037.587.797.53
10.359.829.589.158.849.549.579.229.37
Government0.000.000.000.000.000.000.000.000.00
38.4638.0038.0037.4237.9638.3438.7738.9039.03

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-21
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-21 - Concord Biotech Limited has informed the Exchange about Schedule of meet

2026-08-07
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-07 - Concord Biotech Limited has informed the Exchange about Transcript

2026-08-03
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-03 - Concord Biotech Limited has informed the Exchange about Link of Recording

2026-08-01
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-01 - Concord Biotech Limited has informed the Exchange about Presentation

2026-08-01
Shareholders meeting

2026-08-01 - Concord Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 31, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-01
Copy of Newspaper Publication

2026-08-01 - Concord Biotech Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-31
Shareholders meeting

2026-07-31 - Concord Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 31, 2026

2026-07-31
Outcome of Board Meeting

2026-07-31 - Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-28
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-28 - Concord Biotech Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for CONCORDBIO

Loading news…

🤖

AI Stock Analyst

Concord Biotech Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login